FACULTAD DE CIENCIAS BIOMÉDICAS Y DE LA SALUD
Faculté
![Foto de FACULTAD DE CIENCIAS BIOMÉDICAS Y DE LA SALUD](/img/uploaded/D6B358CC3E52B608E9E4FD2EEC50FA90.jpg)
![Foto de University of Padua](/img/noimage_org.png)
University of Padua
Padua, ItaliaPublications en collaboration avec des chercheurs de University of Padua (43)
2024
-
Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial
Circulation: Cardiovascular Interventions, Vol. 17, Núm. 6, pp. 457-473
-
IMpassion132 double-blind randomised phase III trial of chemotherapy with or without atezolizumab for early relapsing unresectable locally advanced or metastatic triple-negative breast cancer
Annals of Oncology, Vol. 35, Núm. 7, pp. 630-642
-
Low unspliced cell-associated HIV RNA in early treated adolescents living with HIV on long suppressive ART
Frontiers in Immunology, Vol. 15
-
Navigating practical challenges in immunotherapy for metastatic triple negative breast cancer
Cancer Treatment Reviews, Vol. 128
-
Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmission
Nature Medicine
2023
-
Association of HER2DX with pathological complete response and survival outcomes in HER2-positive breast cancer
Annals of Oncology, Vol. 34, Núm. 9, pp. 783-795
-
Effective early antiretroviral therapy in perinatal-HIV infection reduces subsequent plasma inflammatory profile
Pediatric Research, Vol. 94, Núm. 5, pp. 1667-1674
-
Pathologic Complete Response and Individual Patient Prognosis After Neoadjuvant Chemotherapy Plus Anti-Human Epidermal Growth Factor Receptor 2 Therapy of Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 16, pp. 2998-3008
-
Re-Evaluation of Pathologic Complete Response as a Surrogate for Event-Free and Overall Survival in Human Epidermal Growth Factor Receptor 2-Positive, Early Breast Cancer Treated With Neoadjuvant Therapy Including Anti-Human Epidermal Growth Factor Receptor 2 Therapy
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 16, pp. 2988-2997
-
Techniques to improve the accuracy of complete arch implant intraoral digital scans: A systematic review
Journal of Prosthetic Dentistry, Vol. 129, Núm. 6, pp. 844-854
2022
-
Clinical, Virological and Immunological Subphenotypes in a Cohort of Early Treated HIV-Infected Children
Frontiers in Immunology, Vol. 13
-
Determinants of B-Cell Compartment Hyperactivation in European Adolescents Living With Perinatally Acquired HIV-1 After Over 10 Years of Suppressive Therapy
Frontiers in immunology, Vol. 13, pp. 860418
-
Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer
eBioMedicine, Vol. 75
-
Machine learning outperformed logistic regression classification even with limit sample size: A model to predict pediatric HIV mortality and clinical progression to AIDS
PloS one, Vol. 17, Núm. 10, pp. e0276116
-
Optimizing the World Health Organization algorithm for HIV vertical transmission risk assessment by adding maternal self-reported antiretroviral therapy adherence
BMC public health, Vol. 22, Núm. 1, pp. 1312
-
Thalassaemia is paradoxically associated with a reduced risk of in-hospital complications and mortality in COVID-19: Data from an international registry
Journal of Cellular and Molecular Medicine, Vol. 26, Núm. 9, pp. 2520-2528
-
Trends of Phase I Clinical Trials in the Latest Ten Years across Five European Countries
International Journal of Environmental Research and Public Health, Vol. 19, Núm. 21
2021
-
A novel circulating microRNA for the detection of acute myocarditis
New England Journal of Medicine, Vol. 384, Núm. 21, pp. 2014-2027
-
Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study
Annals of Oncology, Vol. 32, Núm. 12, pp. 1571-1581
-
Early ART initiation during infancy preserves natural killer cells in young European adolescents living with HIV (CARMA cohort)
Journal of the International AIDS Society, Vol. 24, Núm. 7